Talk to Geoffrey
+1 718 618 4302
Search inside this page
Publication dates
Publishers
All regions
data types
Free Market Research Guides to Download
» Purchase Premium Reports
1-30 of about 100 reports
This report provides data on the therapeutic development for Rabies, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
This report provides data on the therapeutic development for Hyperphosphatemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
This report provides data on the therapeutic development for Macular Edema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
This report provides data on the therapeutic development for Renal anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Kidney Fibrosis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Kidney Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
Allergies - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Allergies - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...
This report provides data on the therapeutic development for Dyslipidemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
This report provides data on the therapeutic development for Hemophilia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
This report provides data on the therapeutic development for Fibromyalgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Eczema - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Eczema - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...
This report provides data on the therapeutic development for Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Canopus BioPharma Incorporated - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, "Canopus BioPharma Incorporated - Product Pipeline Review - 2012" provides data ...
Takara Bio Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, "Takara Bio Inc. - Product Pipeline Review - 2012" provides data on the Takara Bio Inc.'s research ...
Sosei Co. Ltd. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, "Sosei Co. Ltd. - Product Pipeline Review - 2012" provides data on the Sosei Co. Ltd.'s research ...
Immunomic Therapeutics, Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, "Immunomic Therapeutics, Inc. - Product Pipeline Review - 2012" provides data on the ...
Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, "Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2012" provides data ...
Diabetic Neuropathic Pain - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Diabetic Neuropathic Pain - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. ...
Vyteris, Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, "Vyteris, Inc. - Product Pipeline Review - 2012" provides data on the Vyteris, Inc.'s research and ...
Retinal Degeneration - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Retinal Degeneration - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...
The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...
Hemorrhage - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Hemorrhage - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information ...
Ltd. - Product Pipeline Review - H2 2011? provides a detailed overview on the ViroMed Co., Ltd.?s research and development focus. The report includes information on current developmental pipeline, complete ...
Lymphedema - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Lymphedema - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information ...
NeoStem, Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?NeoStem, Inc. - Product Pipeline Review - 2012? provides data on the NeoStem, Inc.'s research and ...
Raynauds Disease - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Raynauds Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report ...
D-Pharm Ltd. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?D-Pharm Ltd. - Product Pipeline Review - 2012? provides data on the D-Pharm Ltd.'s research and ...
CytoTools AG - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?CytoTools AG - Product Pipeline Review - 2012? provides data on the CytoTools AG's research and ...
Hyperphosphatemia - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Hyperphosphatemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report ...
Harbor Therapeutics, Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Harbor BioSciences, Inc. - Product Pipeline Review - 2012? provides data on the Harbo ...
The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...
» Download Public Reports
52 reports
... That will complement the approval of nanotherm therapy as a medical device. In 2012, the company expects a slight loss reduction compared to the previous year due to the restructuring program initiated in 2011 ...
Reportlinker.com © Copyright 2013. All rights reserved.